Resistance to treatment and change in anorexia nervosa: a clinical overview by Giovanni, Abbate-Daga et al.
Abbate-Daga et al. BMC Psychiatry 2013, 13:294
http://www.biomedcentral.com/1471-244X/13/294RESEARCH ARTICLE Open AccessResistance to treatment and change in anorexia
nervosa: a clinical overview
Giovanni Abbate-Daga, Federico Amianto, Nadia Delsedime, Carlotta De-Bacco and Secondo Fassino*Abstract
Background: Current literature on Eating Disorders (EDs) is devoid of evidence-based findings providing support to
effective treatments, mostly for anorexia nervosa (AN). This lack of successful guidelines may play a role in making
these disorders even more resistant. In fact, many individuals do not respond to the available treatments and de-
velop an enduring and disabling illness. With this overview we aimed to highlight and discuss treatment resistance
in AN – with an in-depth investigation of resistance-related psychological factors.
A literature search was conducted on PubMed and PsychINFO; English-language articles published between 1990
and 2013 investigating the phenomenon of resistance to treatment in AN have been considered.
Discussion: The selected papers have been then grouped into four main thematic areas: denial of illness;
motivation to change; maintaining factors and treatment outcome; and therapeutic relationship. Eating
symptomatology was found to only partially explain resistance to treatment. The role of duration of illness has been
questioned whilst some maintaining factors seemed promising in providing a useful framework for this
phenomenon. Emotive and relational aspects have been investigated on their role in resistance as well as
therapists’ countertransference.
Summary: Remarkably there has been little research done on resistance to treatment in the ED field, in spite of its
clinical relevance. Motivation, insight and subjective meaning of the illness can be useful tools to manage the
resistance phenomenon when coupled with a wider approach. The latter enables the therapists to be aware of
their role in the therapeutic alliance through countertransference aspects and to consider the EDs as disorders of
the development of both personality and self, entailing severe impairments as regards identity and relationships.
Keywords: Anorexia nervosa, Eating disorders, Psychodynamic psychotherapy, Resistance, Change, Insight,
Therapeutic relationship, Maintaining factors, Defense mechanisms, CountertransferenceBackground
Resistance to treatment has been variously interpreted
across psychiatric disorders with this concept being
often used as a synonym of difficult-to-treat disorders.
In literature, there is a general consensus that the avail-
able treatments for major psychiatric disorders fre-
quently result in either a lack of effect or a moderate
response. Accordingly, to challenge treatment-resistance
is fundamental in psychiatric clinical practice and it also
represents a crucial public health problem [1].
Two issues should be carefully addressed while study-
ing the phenomenon of treatment resistance. First, pa-
tients’ apparent strong wish for treatment often not* Correspondence: secondo.fassino@unito.it
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distribution, and reproduction in any mediumresulting in any improvement, and second, the profound
resistance – with conscious and unconscious aspects –
related to the distress triggered by changing [2] which is
a hallmark of Eating Disorders (EDs).
EDs are serious and complex mental illnesses [3] with
a biopsychosocial pathogenesis [4] and that are often
characterized by a chronic and disabling course [5].
Recent follow-up studies failed to provide evidence that
treatments can influence long-term results [6] with rele-
vant consequences on public health-related costs [7-9].
The only exception is represented by adolescents af-
fected by anorexia nervosa (AN) reporting a more favor-
able outcome when compared to adults [10]. In fact,
one-third of adult AN patients show poor outcome also
because of an enduring and refractory illness [5,11]entral Ltd. This is an open access article distributed under the terms of the
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atology are less entrenched in younger patients [10].
In AN, both avoidance of treatment [12] and dropouts
- ranging between 20 and 51% in the inpatient popula-
tion and from 23 to 73% in outpatient samples – are re-
lated to the great difficulty existing in engaging and
maintaining their treatment adherence [13,14].
In AN, willingness to improve represents only one of
several factors required to achieve recovery. In fact, reluc-
tance to recover is sustained by ego-syntonic symptoms
that reinforce the illness [15-17] and relapse is common
[18,19] also because patients often perceive consequences
of AN as positive and adaptive [20]. Symptoms and patho-
logic beliefs are indeed intertwined in AN, revealing a
self-protecting meaning. Eating psychopathology is under-
pinned by several entangled biopsychosocial elements -
personality, general psychopathology, environment, and
treatment itself - that may have a role in both increasing
and lowering patients’ willingness to recover.
For many years, the possible meanings of eating symp-
tomatology have been debated; studies investigating pa-
tients’ perspectives have finally demonstrated how patients
often describe AN as a means of obtaining identity, avoid-
ing negative emotions, and satisfying a strong need for
control [21]. Patients are reluctant and ambivalent about
changing and they can unconsciously oppose a strong re-
sistance to their therapists’ efforts towards improvement.
Defense mechanisms that protect patients by negative
feelings are often directly activated by therapy paving
the way to resistance [2]. The peculiar defense mecha-
nisms in AN – denial and intellectualization – can be-
come resistance to treatment when patients are asked
to face both changes and negative affect [22,23]. AN
should be considered indeed not only as a constellation
of physical and psychological symptoms but also as an
array of self-protecting behaviors able to give patients
respite from distress [24].
Although these aspects are well-known to clinicians,
there is a dearth of organized and critical studies in the AN
field on resistance to treatment and motivational therapies.
The aim of the present paper is to gather and discuss
the studies published from 1990 to 2013 on the topic of
treatment resistance in AN since a better understanding
of poor motivation to treatment is fundamental to pro-
vide more tailored therapies. The research questions
underpinning this article arose from the need of a dee-
per understanding of 4 core areas with regard to AN
treatment: namely, we considered the role of: 1. illness
awareness; 2. patients’ willingness; 3. psychopathological
factors ED symptomatology-related; 4. therapist.
Methods
Article search has been conducted using PubMed and
PsychINFO databases using the following MeSH terms:“anorexia nervosa”, “bulimia nervosa”, “eating disor-
ders”, “motivational change”, “insight”, “predictors of
outcome”, “treatment resistance”, “decision making”,
“psychosis”, “countertransference”. The first three terms
have been alternately used as fixed research criteria.
This MeSH search yielded 142 articles pertaining to
treatment resistance in EDs.
Abstracts or full texts have been then gathered and se-
lected by two different researchers (ND and AF) to
check the following inclusion criteria: a) AN diagnosis;
b) original research or debate articles, c) being published
after 1990, and d) English language. Exclusion criteria
were: a) samples diagnosed with unstandardized instru-
ments or according to unspecified criteria; b) case re-
ports; c) letters; and d) editorials.
We decided to include not only original research but
also debate articles for two major reasons. First, to date
the relationship with patients has been scarcely investi-
gated, mostly by qualitative studies and debate-framed
articles. Second, currently there is such a dearth of
evidence-based data in the treatment of AN that the
opinion of highly experienced researchers and clinicians
is extremely valuable.
According to the aforementioned criteria we finally se-
lected 71 articles to be included in this overview whilst
71 have been excluded because not meeting the inclu-
sion criteria.
We could not perform a meta-analysis because of the
differences we found among studies regarding sample
composition, methodology used in the assessment of pa-
tients, and different outcome criteria. To achieve greater
clarity, the gathered articles have been divided into four
thematic areas grounded on the 4 aforementioned research
questions (1. role of illness awareness; 2. role of patients’
willingness; 3. role of psychopathological factors ED
symptomatology-related; 4. therapist’s role): denial versus
insight of illness; motivation to change; maintaining fac-
tors and treatment outcome; therapeutic relationship,
countertransference, management of treatment resistance
(see Table 1). Studies encompassing more than one area
have been distributed under more sections.
Results
Sample composition
We included in this overview 71 studies with a variable
sample composition ranging from 14 to 748 participants.
No reviews or meta-analysis on this topic were available.
Three of the considered studies recruited clinicians
instead of patients [85,87,90] to investigate their coun-
tertransference. As regards the study design, we found
debate articles, randomized controlled trial (RCT), quali-
tative interview, test validations, longitudinal cohort,
cross-sectional, prospective cohort, and retrospective
cohort studies (see Table 1).
Table 1 Articles included in the clinical overview; they have been divided into 4 thematic areas based on 4 research questions: 1. role of illness awareness; 2.
role of patients’ willingness; 3. role of psychopathological factors 4. therapist’s role
Thematic area Number of
articles
Authors Number of patients Diagnoses Type of study
Denial versus insight of illness 7
Couturier & Lock, [25] 86 AN Retrospective cohort
Gothelf et al., [26] 281 37 AN;163 other psychiatric
disorders; 81 HC
Cross sectional
Konstantakopoulos et al., [27] 75 25 AN; 15 BN; 35 HC Cross sectional
Konstantakopoulos et al., [28] 72 39 AN; 33 BN Cross sectional
Schoen et al., [29] 14 AN; BN (no subgroups) Retrospective cohort
Steinglass et al., [30] 25 AN Cross sectional
Viglione et al., [31] 38 AN Cross sectional
Motivation to change 33
Ametller et al., [32] 70 AN Prospective cohort
Ben Tovim et al., [33] 220 95 AN; 88 BN; 37 EDNOS Longitudinal cohort
Bewell et al., [34] 127 AN Prospective cohort
Burket & Hodgin, [35] 72 49 BN; 11 ANBP; 6 EDNOS; 6 ANR Retrospective cohort
Carter et al., [36] 100 AN Prospective cohort
Casasnovas et al., [37] 218 58 AN; 95 BN; 65 EDNOS Cross sectional
Cavedini et al., [38] 38 AN Prospective cohort
Clausen, [39] 78 35 AN; 30 BN; 13 EDNOS Prospective cohort
Danner et al., [40] 16 AN Cross sectional
Darcy et al., [41] 20 AN Cross sectional
Gale et al., [42] 202 62 BN; 140 AN Cross sectional
Geller et al., [43] 99 15 ANBP ; 32 ANR ; 41 ANST; 7 BN;
4 BNST
Test validation
Geller et al., [44] 63 24 ANR; 12 ANBP; 21 ANST; 7 BN Prospective cohort
Geller et al., [45] 128 10 ANR; 9 ANBP; 46 BN; 61 EDNOS Longitudinal cohort
Herzog et al., [46] 246 61 AN; 95 BN; 90 EDNOS Prospective cohort
Karlsson et al., [47] 89 AN Prospective cohort
Konstantakopoulos et al., [28] 72 39 AN; 33 BN Cross sectional
Lund et al., [48] 79 AN Prospective cohort
McHugh et al., [49] 65 AN Prospective cohort
Mewes et al., [50] 100 AN Prospective cohort
Muñoz et al., [51] 385 61 AN; 47 BN; 245 EDNOS Prospective cohort
Nordbø et al., [20] 18 AN Cross sectional
Nordbø et al., [52] 18 AN Cross sectional
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Table 1 Articles included in the clinical overview; they have been divided into 4 thematic areas based on 4 research questions: 1. role of illness awareness; 2.
role of patients’ willingness; 3. role of psychopathological factors 4. therapist’s role (Continued)
Nordbø et al., [53] 36 AN Cross sectional
Ricca et al., [54] 103 53 AN; 50 ANST Prospective cohort
Rieger et al., [55] 44 AN Test validation
Salbach-Andrae et al., [56] 57 AN Prospective cohort
Schebendach et al., [57] 47 AN recovered Prospective cohort
Steinglass et al., [30] 25 AN Cross sectional
Touyz et al., [58] Debate article
Treasure et al., [59] Debate article
Wade et al., [60] 47 AN Prospective cohort
Ward et al., [61] 35 22 ANR; 11 ANBP; 2 BN Cross sectional
Maintaining factors and treatment outcome 22
Castro et al., [62] 158 AN Prospective cohort
Clausen, [39] 78 35 AN; 30 BN; 13 EDNOS Prospective cohort
Danielsen & Rø, [63] 50 30 AN; 9 BN; 11 EDNOS Prospective cohort
Deter et al., [64] 81 AN Prospective cohort
Fairburn et al., [65] Debate article
Fassino et al., [66] 40 AN Prospective cohort
Fassino et al., [67] 42 AN Prospective cohort
Fassino et al., [68] 57 28 AN; 29 BN Prospective cohort
Federici & Kaplan, [69] 15 AN Cross sectional
Fichter et al., [18] 103 AN Prospective cohort
Geller et al., [70] Debate article
Goddard et al., [71] 74 63 AN; 7 BN; 4 EDNOS Prospective cohort
Helverskov et al., [72] 312 58 AN; 68 EDNOS-AN; 111 BN; 75
EDNOS-BN
Prospective cohort
Hjern et al., [73] 748 AN Prospective cohort
Löwe et al., [74] 84 AN Prospective cohort
Salbach-Andrae et al., [56] 57 AN Prospective cohort
Schmidt & Treasure, [75] Debate article
Signorini et al., [76] 58 AN Prospective cohort
Steinhausen et al., [77] 60 48 ANR; 6 ANBP; 5 Atypical AN; 1
BN
Prospective cohort
Sutandar-Pinnock et al., [78] 73 AN Prospective cohort
Treasure & Russell., [10] Debate article
A
bbate-D
aga
et
al.BM
C
Psychiatry
2013,13:294
Page
4
of
18
http://w
w
w
.biom
edcentral.com
/1471-244X/13/294
Table 1 Articles included in the clinical overview; they have been divided into 4 thematic areas based on 4 research questions: 1. role of illness awareness; 2.
role of patients’ willingness; 3. role of psychopathological factors 4. therapist’s role (Continued)
Vrabel et al., [79] 74 13 AN; 37 BN; 24 EDNOS Prospective cohort
Therapeutic relationship, countertransference, management of
treatment resistance
18
Carter et al., [36] 100 AN Prospective cohort
Darcy et al., [41] 20 AN Cross sectional
Federici & Kaplan, [69] 15 AN Cross sectional
Feld et al., [80] 19 8ANR; 4ANBP; 4 BN; 3 EDNOS Prospective cohort
Forget et al., [81] Debate article
Geller et al., [82] 181 Cases: 3 ANBP; 4 ANR; 22 BN; 28
EDNOS
RCT
Controls:3 ANBP; 4 ANR; 21 BN; 28
EDNOS
Gulliksen et al., [53] 38 AN Cross sectional
Karlsson et al., [47] 89 AN Prospective cohort
Masson & Sheeshka, [83] Qualitative interview
Moyers & Rollnick, [84] Debate article
Satir et al., [85] 120 (HP) Cross sectional
Skårderud et al., [24] Debate article
Strober et al., [86] Debate article
Tierney & Fox, [87] 53 (HP) Cross sectional
Tozzi et al., [88] 70 AN Cross sectional
Treasure et al., [59] Debate article
Vitousek et al., [89] Debate article
Warren et al., [90] 43 (HP) Cross sectional
AN Anorexia Nervosa, BN Bulimia Nervosa, ANR Anorexia Nervosa Restricting subtype, ANBP Anorexia Nervosa Binge-Purging subtype, EDNOS Eating Disorder Not Otherwise Specified, ANST Subthreshold Anorexia Ner-
vosa, BNST Subthreshold Bulimia Nervosa, EDNOS-AN anorexia-like eating disorder not otherwise specified-anorexia nervosa, EDNOS-BN anorexia-like eating disorder not otherwise specified-bulimia nervosa, HC Healthy
Controls, HP healthcare practitioners, RCT randomized controlled trial.
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As regards ED diagnosis, according to Diagnostic and
Statistical Manual criteria (DSM-IV-TR) [91], 32 studies
included only AN individuals, in one case recovered-
AN; 9 papers considered bulimia nervosa (BN) and AN
individuals, in one case compared to healthy controls
(HC); 14 studies AN, BN and eating disorder not other-
wise specified (EDNOS) participants. A study compared
AN patients with subthreshold-AN individuals. In an-
other work have been included patients with other psy-
chiatric diagnoses and HC. The remaining studies were
debate articles or did not consider affected individuals.
Thematic areas
Denial versus insight of illness (7 studies)
Konstantakopoulos and Coworkers [27] highlighted how
the restricting AN subtype is strongly characterized by
lack of insight of illness and how the latter correlates
with cognitive flexibility as measured with the trail mak-
ing test. A couple of studies included in this area under-
scored that poor insight can assume delusional features,
defining then a specific subgroup of AN patients even
more treatment-resistant [28,30].
Moreover, two studies highlighted how insight of illness
can be a helpful element in overcoming scarce compliance
with therapy. Schoen and Coworkers [29] in a recent
paper demonstrated a correlation between insight of ill-
ness and the seeking of professional treatments whilst
other authors [31] supported indeed that duration of
illness correlates with greater insight rather than with a
more severe disorder.
Other three studies toned down the role of insight in
overcoming poor compliance to treatments: it could be
not only the lack of insight to maintain the disorder but
also the combination of mature and immature defense
mechanisms [26]. In fact, the majority of treatment-
resistant patients show a clear denial of illness rather
than scarce insight [27]. Moreover, it has been recently
shown by the same authors – not in line with previous
studies [31] – that insight is not related to duration of
illness and that poor insight can be maintained also in a
chronic phase of the ED [27]. Finally, Couturier and
Lock [25] demonstrated how denial of illness does not
impact significantly the outcome of family therapy.
Motivation to change (33 studies)
A few studies evaluated psychological determinants of
motivation to change and only one paper investigated
the correlation between motivation to change and qual-
ity of life as perceived by patients [51] but - given its
cross-sectional design - it is not clear whether motiv-
ation can be influenced by quality of life or vice versa.
As regards cognitive factors, only one paper [38]
found neurocognitive traits, in particular decisionmaking impairment, as possibly involved in determin-
ing a less favorable outcome after Cognitive Behavioral
Therapy (CBT), as well as lower weight gain and
poorer motivation to change. AN patients would be
cognitively oriented to choose short-term rather than
long-term rewards with these features entailing poorer
compliance to treatments and a less positive outcome.
Recently, Danner and Coworkers [40] highlighted a
significant correlation between set-shifting and central
coherence raising the hypothesis of a relevant link – as
regards prognosis – between these traits and treatment
outcome. However, the authors underscored also that
such deficits are shared by both ill and recovered-AN
individuals so they cannot be predictors of motivation
to change.
Eleven studies included in this thematic area investi-
gated quality and content of motivation. Three studies
conducted by Nordbø and Coworkers demonstrated that
a treatment independent willingness to recover is a funda-
mental requirement to readiness to change [17,20,52] and
another work showed that patients’ willingness to change,
as expressed at the beginning of treatment, is a relevant
prognostic factor at six-month follow-up [47]. In line with
these findings, an improved motivation to change during
therapy represents a crucial factor in overcoming relapses
[36]. All these studies highlight how patients’ attitudes to-
wards illness should be accounted for while defining mo-
tivation to change [20] and investigated at the beginning
of treatment [51].
It is noteworthy that those motivations verbally expressed
by patients often do not correspond to an authentic
intention to modify their eating disordered behaviors
since ED patients can be strongly ambivalent about chan-
ging [52]. The ambivalence issue has been confirmed also
by another study [42] suggesting the use of the Pros and
Cons of Eating Disorders Scale as useful tool to evaluate
patients’ perspective of illness. Moreover, a longer dur-
ation of illness – index of poor motivation to change – is
a negative prognostic factor mostly in AN [39].
Another paper investigated preoccupation with weight
and body and found it to be determinant as regards
CBT outcome and the chance to overcome treatment re-
sistance [54]. The intensity of such a preoccupation can
assume a delusional connotation with repercussions on
resistance to treatment by lowering motivation [28] and
generating strong ambivalence [30].
Twelve studies highlighted the correlation between pa-
tients’ clinical features and their motivation to change. In
fact, BN patients are usually more motivated to seek treat-
ment and change than both AN and subthreshold-AN in-
dividuals, mostly if chronic [37], and there is general
consensus that binge-purging AN individuals show an un-
favorable outcome [56]. Another recent study suggested
indeed a more positive prognosis for EDNOS individuals;
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and showed indexes of higher motivation when compared
to individuals affected by a full diagnosis [39], providing
further support to data already known in literature
[33,46]. Those patients with normal body mass index
(BMI), showed a more rapid improvement in motivation
to change than those with a low BMI [45] and, more in
general, baseline BMI was the most significant predictor
of outcome in the whole ED diagnostic group [39]. More-
over, poor motivation to change correlated also with laxa-
tives abuse, depression, and body dissatisfaction [35],
although some researchers [35] could not find a correl-
ation between clinical severity and poor motivation to
treatment, even if more recent studies did not confirm
this hypothesis [45]. However, two studies [48,50] indi-
cated that the rapidity of weight restoration is the only
significant prognostic factor over the short and medium-
term with Lund and Coworkers [48] highlighting indeed
how this can indirectly point out an enhanced motivation
to treatment. Finally, Schedenbach and Colleagues [57]
underscored that the best predictors of treatment out-
come are the ability to choose a variety of foods, mostly
with high caloric density.
Eleven studies highlighted how motivation to change can
quantitatively vary and several papers on AN described dif-
ferent stages of change and their influence on both out-
come and resistance. Some authors demonstrated that the
extent of clinical improvements can vary also depending on
the stage of motivation achieved by patients [61] and that a
mismatch between stage of motivation and phase of treat-
ment can enhance resistance to treatment [58]. Other stud-
ies correlated motivation-to-change levels to the need and
duration of hospitalizations, finding that high motiv-
ation correlates with short duration of inpatient treat-
ment and better outcome [49]. Conversely, if the
motivation level is low – i.e. pre-contemplation phase
according to Prochaska’s model [92] – the need for hos-
pitalizations resulted to be higher [32].
Motivation to change can be improved by sharing
treatment plans with patients [41] and can be assessed
with the Motivational Interview [93], the Readiness
and Motivation Interview [43,44], or the Anorexia
Nervosa Stages of Change Questionnaire [55]. Some
studies showed that the latter is a useful instrument to
predict changes in eating symptomatology [60] and
outcome since motivation plays a mediator role be-
tween them [34].
Maintaining factors and treatment outcome (22 studies)
Although early studies discouraged the search for ED-
specific maintaining factors highlighting instead the need
of long-term treatments [77], some recent papers called
into question the need for their identification and refor-
mulation [70].Fairburn [65] designed a transdiagnostic cognitive-
behavioral therapy for EDs, aiming at addressing main-
taining factors; he individuated as main element a scheme
of dysfunctional self-evaluation by which patients attribute
exaggerated relevance to eating, body shape, and weight.
He considered both ED-specific factors (i.e. thoughts
about eating, weight, body shape, hyperactivity) and non
ED-specific factors like low self-esteem, interpersonal
problems, emotional intolerance, and perfectionism. The
latter interact with both individual’s specific psychology
and other maintaining factors [65].
Perfectionism has been considered also by other au-
thors [78], demonstrating that some of its aspects could
represent a transitional status associated to pathology
and are no longer present in recovered AN individuals.
In addition, more authors individuated in body image
an outcome predictor of hospitalization even more reli-
able than interpersonal problems and general psycho-
pathology pointing out indeed how body perception
instead of body dissatisfaction can be an indicator of
treatment progression [63].
Other psychopathological factors with prognostic
value were: inadequacy, high asceticism and maturity
fear, impulsivity, and sexual problems [18,66-68]. As
regards intra-psychic elements instead, one study indi-
viduated as ED maintaining factors poor problem solv-
ing and relational skills [69].
Five studies considered personality traits as ED maintain-
ing factors. Fassino and Coworkers [66-68] pointed out
how low novelty-seeking and high harm-avoidance – along
with other psychopathological aspects – represent predic-
tors of poor outcome in an ED multimodal treatment.
Other studies [76] demonstrated instead that narcissistic
personality traits were related to strong resistance to
weight gain in treated AN individuals and that depressive
and psychotic traits entailed better or poorer prognosis,
respectively. Another paper [73] with a 9 and 14-year
follow-up found that Axis I and II psychopathology could
predict both poor outcome and numerous hospitalizations
in the ED population. A couple of studies [56,64] con-
firmed the negative role of general psychopathology on
AN prognosis at the 12-year follow-up, whilst another
paper [39] found it significant mostly about BN.
Further authors [79] underscored indeed how avoidant
personality traits, coupled with a history of sexual abuse,
can play a negative role on long-term prognosis after
hospitalization. Assuming a categorical approach to
study personality, Helverskov and Coworkers [72] ac-
knowledged the presence of a personality disorder as a
negative prognostic factor shared by all EDs.
Castro and Colleagues [62] investigated the prognostic
meaning of parental bonding on the outcome of short-
term therapy in AN. Even highlighting how parental
bonding was not particularly different from healthy
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control as well as having a rejecting father entail are
both elements that strongly impact treatments, in
addition to ED psychopathology. Recently, some authors
[71] supported the role of caregivers’ expressed emotions
and reinforcing behaviors as interpersonal maintaining
factors. In their work it has been indicated that reducing
caregivers’ distress leads to improving patients’ function-
ing and eating pathology.
Schmidt and Treasure [75] considered as maintaining
factors both intrapersonal and interpersonal factors, pla-
cing only scarce emphasis on biological elements and
body weight. Also Treasure and Coworkers [94] ana-
lyzed the interpersonal maintaining factors of EDs point-
ing out that over protection, coercive treatments, and
isolation could be iatrogenic factors.
Finally, two papers investigated psychosocial factors as
the lack of a partner, poor family support, and un-
employment as relevant predictors of poor outcome at
21 [74] and 12-year follow-up [64]. Another study [39]
showed how the scarcity of friends is a negative prog-
nostic factor in EDNOS patients.
Therapeutic relationship, countertransference and
management of treatment resistance (18 studies)
The studies considered in this thematic area – deepen-
ing poor compliance and scarce motivation to treat-
ments – indirectly suggested different models to treat
resistant patients.
Carter and Colleagues [36] highlighted how improving
and maintaining motivation to treatment during therapy
can show a relevant impact on the long-run. Accordingly,
it has been shown the need to specifically address motiv-
ation as much as social relationships and body image with
tailored interventions to obtain an adequate weight restor-
ation, even with acute AN patients [47].
A couple of studies illustrated rehabilitation – with a
focus on psychosocial interventions [87] or supportive
therapy [86] - constantly advocating the need for tailored-
to-person treatments.
Five studies suggested interventions focused more
directly on overcoming poor compliance to treatments
with an approach aiming at improving motivation
to change and treatment. Already Vitousek and
Colleagues years ago [89] underscored the importance
of improving motivation to change. With their paper,
they suggested some cognitive-behavioral strategies
that can be applied also to other theoretical models to
enhance emotively and cognitively the therapeutic
alliance to overcome resistance. In fact, the authors
highly recommend to emotionally validate patients by
accepting their difficulties and by speaking their lan-
guage, adopting a Socratic style in the exploration of
both ambivalence and resistance to treatment.Another effective intervention was the Motivational
Interview, an approach based on the Socratic method,
emphasizing patients’ autonomy and discouraging
direct persuasion [84]. Geller and Coworkers [82]
demonstrated the effectiveness of Readiness and
Motivation Therapy to lower ambivalence and improve
change; also Motivational Enhanced Therapy was
found to be effective to achieve this goal, even if in a
less structured way [80].
A theoretical paper [83] highlighted that clinical inter-
ventions should sometimes indulge patients’ resistances;
the discharge of poorly motivated patients can be neces-
sary to maintain a therapeutic milieu focused on recov-
ery and to avoid poor compliance [83,89].
Finally, other studies suggested interventions to over-
come scarce compliance not directly focusing on pa-
tients but rather on therapists, highlighting the need to
handle correctly their countertransference since it could
play a negative role on treatment [59,85]. Countertrans-
ference can be determined by both patients’ [95] and
therapists’ features [53,90] and supervision of therapist’s
emotions is highly recommended [81].
Patients highly value psychotherapy and therapeutic
relationship considering them as useful elements in
treatment [69,88]. Accordingly, it has been suggested to
work with a particular focus on the patient-therapist
interaction and on shared choices [41]. Concluding, a
comment article proposed indeed to address the impair-
ment in mentalization skills of ED patients within the
therapeutic relationship [24].
Discussion
The aim of the present paper was to provide a clinical
overview of the available literature on resistance to treat-
ments in AN. It is indeed a well-known phenomenon
theorized decades ago [89,96,97] that represents a heavy
burden for all clinicians [98]. We propose here a scien-
tifically informed discussion since a systematic review of
the literature has been hampered by a huge variety of
methodologies used in the available studies leading to a
lack of comparable data. Therefore, a systematic review
of the literature to date would lead only to scarcely pow-
ered findings. As a further limitation, it should be born
in mind that the biopsychosocial pathogenesis of AN
would require to study several sources of knowledge.
We will focus on psychosocial factors and emotive and
relational impairments, omitting the biological aspects
like the effects of starvation on brain functions.
But why is there a dearth of studies on resistance? This
apparent disinterest seems to be due to several reasons.
Firstly, it is likely that many authors conceive resistance
to treatment as a whole with the illness. According to
this perspective, the investigation of treatment outcomes
in AN would correspond to evaluating resistance too
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phenomenon. Hence, some of the papers we included in
this overview [14,54,100] pointed out how treatment-
resistance in the AN field can be easy to notice but diffi-
cult to understand. In fact, it is a complex phenomenon
that involves vulnerability and maintaining aspects with
intertwined biological, psychopathological, and social
features [101] that cannot be easily disentangled.
Thirdly, in the last years, research focused more on
resistance-related biologic aspects [102] rather than on
clinical and relational ones [98]. Also psychodynamic
psychotherapies have been even less studied although
the assessment of resistance represents the core of the
psychoanalytic method [103] since resistance can be en-
hanced by the relationship between patient and therap-
ist. Finally, we could call into question clinicians' poor
motivation to study their frustrated therapeutic attempts
[94]. Whatever the reason, it may be a mistake not to
carefully consider this phenomenon since it is a hallmark
of psychiatry [104]. More in detail, since psychotherapy
is an effective therapeutic instrument in the ED field, a
better understanding of both resistance and strategies to
address it should be carefully considered in treatments
[2]. From the research questions underpinning this art-
icle we sorted our results into four core areas with re-
gard to AN treatment.
Denial versus insight of illness
This is the most immediate and straightforward correlate
of resistance to treatments in AN and it was included
even in DSM-IV-TR diagnostic criteria [91]. Denial of ill-
ness is defined as the refusal to acknowledge and accept
one’s own illness and it refers not only to psychodynamic
therapy and defense mechanisms [2] but also to a wider
definition of disadaptive coping [105]. Denial of illness is
an intrinsic factor of the first phases of AN [91] and it can
last years [86], given the ego-syntonic nature of the anor-
ectic disorder [106]. Accordingly, the Academy of EDs has
clearly stated that EDs are severe mental illnesses that re-
quire a wide and multifaceted health care alert as like as
other major psychiatric pathologies including bipolar dis-
order, schizophrenia, obsessive-compulsive disorder or de-
pression [3].
We included 7 studies converging on the fact that a
large number of AN patients deny their disorder
[25-31]. This phenomenon can be particularly clear for
those patients who need acute hospitalizations: a recent
study conducted on a sample of 108 AN inpatients
showed that the vast majority of them (63%) deny their
illness [107] with 20-30% of cases revealing a symptom-
related psychotic status [28,30]. These features may be
so widespread because many patients tend to carry out a
deliberate denial [27] or minimization [25] of their ill-
ness trying to justify – with different degrees ofawareness - treatment refusal. In this regard, the data
in literature are debated and do not clarify whether de-
nial of illness is a psychosis-like symptom or rather a
rigid and disadaptive defense mechanism helping pa-
tients to protect themselves by anxiety and depression
[26,31] and to avoid treatments [89] or negative emo-
tions [22,23]. It is likely that both these aspects are
true; nevertheless, hypothesizing denial as a defense
mechanism could be more in line with its time
consistency [86], independently of fluctuations in ED
symptomatology [28,29].
Data are also controversial about the extent to what
denial can impact prognosis since this element seems to
be scarcely relevant as regards adolescents [25]. One
paper highlighted a linear correlation between insight
and duration of illness [31], although this finding has
not been replicated [28]. At now, it is not possible to
distinguish whether denial is already expressed at the
onset of illness or it is enhanced with time and poten-
tially by inappropriate treatments. However, it should be
considered as a central issue to be addressed in treat-
ments rather than a prognostic element [29].
The improvement of insight of illness could be an
index of a good therapeutic alliance [108]. In fact, the
therapeutic relationship is now indeed considered as
the most effective instrument to contrast denial of
illness [75,109].
In sum, denial of illness, a shared factor with other se-
vere mental disorders [110], was not found to be a pre-
dictor of resistance to treatment but rather to correlate
with the phenomenon of treatment resistance.
Motivation to change
Papers on motivation to change in AN allowed a better
understanding of denial of illness although one main dif-
ficulty encountered in this field of research is to under-
stand patients’ authentic degree of motivation to recover
since there is often a difference between what patients
do and say [100].
Studies on motivation to change (33 included in this
clinical overview) suggested ways to measure this con-
struct [17,20,28,30,32,34-52,55-57,60,61] and interven-
tions to enhance it [33,58-60]. A lower motivation to
change was found to correlate with lower BMI [45] -
and in general a more severe eating and general psycho-
pathology [35,39,54]-full diagnosis, purging behaviors
[33,45,46,56], lower compliance to dietary recommenda-
tions and slow weight gain [48,50,57], and worse quality
of life [51]. These data are in line with Kaye’s hypothesis
of a vicious cycle of symptoms as maintaining factors in
EDs [102].
From the available body of literature emerged a correl-
ation between motivation and psychopathology, even
more peculiar in AN than BN [37].
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date it is still controversial whether motivational inter-
ventions can be a main road to improve resistance to
treatment or not. There is a significant correlation be-
tween willingness to recover and good motivation to
change [36], but this association is variable and scarcely
supported by other studies [32,34,49,60,61]. Moreover,
willingness to recover [52,100,111] or the ability to
recognize the negative effects of illness [37] can be con-
fused with motivation to change and this misinterpret-
ation could lead not experienced therapists to enhance
resistance through its underestimation. In fact, some
studies highlight the need to train therapists to notice,
understand and value those emotions that usually under-
pin AN [97,108,112].
The role of neuropsychological aspects – promising
and growing research area [113] – is even less studied
and the data in literature are contrasting [38,40]: in fact,
cognitive rigidity and impaired decision making – stable
traits also in recovered individuals - can only partially
represent a hindrance to treatments.
Although several lines of evidence exist in support of
motivational interventions [58-61], a recent review con-
ducted by Waller [100] questions their effectiveness since
the available studies are frequently biased by methodo-
logical flaws. In fact, motivational interventions are not
stand-alone treatments; therefore, the psychotherapies (i.e.
CBT) that they usually support could be responsible for the
real effectiveness of these interventions. Hence, motiv-
ational interventions – as to date have been described in
literature – can only scarcely impact motivation and failed
to significantly improve outcomes with the only exception
represented by Binge Eating Disorder patients [100]. Other
findings did not provide support for the effectiveness of
such interventions with long-standing patients [83].
Some hypotheses could be raised to bridge the gap as
regards motivation to change: a) too much emphasis
has been placed on words instead of facts [100] with-
out considering patients’ peculiar strive to please [97]
and need for approval [108]; b) motivation has been
conceived as a too linear concept whilst patients can-
not switch directly from one stage to another; c) the
assessment of motivational stages is not adequately
considered during treatment planning: often motiv-
ational stage and phase of therapy do not match, hav-
ing resistance to treatments enhanced as a result
[51,58]; d) motivational models may be too simple and
may not to consider patients’ ambivalence in an proper
manner [70,114,115]; e) an excessive use of verbal per-
suasion is usually made at the expense of patient au-
tonomy [100,116].
Therefore, only a few studies tried to investigate the
process of recovery in AN and to conceptualize more in
detail ambivalence to change and its implications [17].Ambivalence and meaning of illness
In this sense, some papers [17,20,43-45,70] highlighted
the relevance of both motivation and pervading ambiva-
lence that paralyzing patients while making their deci-
sions. Some authors pointed out the existence of a sort
of “anorexic voice”, an inner entity disapproving patients
and being sometimes overwhelming in respect to their
sense of the self [117,118]. This voice is even more per-
vading when the illness gets worse, contributing to ham-
per treatments. It has been suggested that the link
between patients and this AN voice could play a role in
unravelling the issue of ambivalent attitudes towards
change, typical of BN individuals too [70]. Thus AN and
BN patients would constantly struggle between facing
resistance to treatment or valuing it.
From a therapeutic perspective, it could be useful to
become familiar with the adaptive function of AN and
its pros and cons, as experienced by the patients
[70,115]. Therefore, it becomes possible not only to per-
form a cognitive restructuring, but also to mitigate their
distress [24] with two aims: a) to use the empathic ap-
proach to understand patients’ inner world [89] and to
dialogue on both diagnosis [119] and recovery meanings
[17]; b) to move the focus of the intervention from
pathological beliefs to therapeutic relationship [120].
One way to start addressing resistance to treatment in
ED patients is trying to understand the subjective mean-
ings of the illness [75] and patients’ environment [121].
We found 5 articles that consider in detail patients’
meanings of the disorder and they all agree on consider-
ing the “positive” functions of AN as enhancing treat-
ment resistance [20]. In fact, the ED can be a way to feel
safe, avoid threatening emotions, communicate with
others, and feel strong, special and in control [21].
Considering patients’ perspectives for treatments could
have several positive implications. First, patients feel
themselves as empathically understood [83,108,122,123];
second, it becomes possible to deepen and personalize
the comprehension of those feelings that underpin the
ED [97] since they can be very different between patients
[20]. Third, it is possible to introduce mind and cogni-
tions in therapy – in addition to eating behaviors and
body distortions - to avoid resistance and relapses [124]:
in fact, if decades ago therapies tended to be excessively
focused on family and intra-psychical aspects, now we
could incur an opposite risk. Weight restoration should
be the starting point of a treatment instead of its main
goal. The eating pathology should be considered more
as a disturbance of corporeality and as an impairment
of embodiment [125] rather than a neurological body
image distortion [126]. Fourth, talking about what pa-
tients think and feel about the meaning of their illness
could provide a therapeutic framework, enabling them
to experience their autonomy [120] and supporting an
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the illness without “being with” the patient [16].
However, the attention to the meanings that patients
confer to their disorder is a necessary but not sufficient
condition to understand the phenomenon of resistance
to treatment. In fact, the therapist risks to become
emotionally indulgent with iatrogenic and resistance-
enhancing results [94]. It is crucial for the therapist to
achieve a “firm empathy” [127] because an empathic
understanding of the patient is not enough; firm boundar-
ies are of vital importance to counterbalance empathy in
the therapeutic relationship. Such elements are not only
cognitive but have also a relational meaning and function.
Therapists need to address patients’ need for boundaries,
even if not verbally expressed. The treatment, with its im-
plicit relational instruments [128], enables patients to per-
ceive their therapists as both holding [97,129] and
handling [89,129] their self-harming attempts. This could
be the result of the struggle for control to achieve a sense
of identity that Bruch pointed out decades ago highlighting
also that for many AN individuals “the experience of being
listened to appeared to be of utmost importance … instead
of having their feelings and the meaning of their communi-
cation interpreted” [97]. This balance between the two ele-
ments – firmness and empathy - can promote changes in
patient’s personality and coping through interiorization.
Certain pathological behaviors should not be allowed or
clearly prohibited. At the same time, it is useful to under-
stand patients’ resistances, objections and even their need
to feel alone, refused, and poorly understood.
Therapists may also incur the risk to consider only pa-
tients’ conscious meanings of illness and to underestimate
those unconscious, deeper, and even more distressing. In
this sense, conscious meaning can over the long-term hide
useful elements in treatment and therefore contributing to
treatment-resistance [75].
In sum, the clinical effort performed on the meanings of
illness – either conscious or not – could help overcome re-
sistance to treatment. The understanding of patients’ inner
world and attitudes towards the illness can become an op-
erational tool to address the core of treatment-resistance
within the therapeutic relationship.
Maintaining factors and treatment outcome
The complex available models to address resistance to
treatment are mainly focused on AN maintaining factors
and with this overview we found 22 articles investigating
this research area showing interesting and well-organized
models [11,18,39,56,62-79]. The shared core is the atten-
tion to both “symptom treatment” eventually entailing a
vicious cycle [5,18,66-68] and negative effects of starvation
on brain [130]. Also body image distortions should be ad-
dressed in detail [63,65] and body dissatisfaction has been
found to correlate with certain styles of attachment [108].There is robust evidence showing that mental health can-
not be reached without recovery of weight, body percep-
tion, obsessive thinking on food and body and without
regaining a good quality of life.
Moreover, the different models consider personality
and interpersonal aspects as premorbid or maintaining
factors. Several factors have been called into question as
enhancing treatment resistance: 1) low self-esteem and
2) mood intolerance [65]; 3) perfectionism [65,78];
4) body experiences [17,125]; 5) general psychopathology
[39,56,64]; 6) personality [66-68,72,73,76,79]; 7) interper-
sonal relationships [65,75]; 8) cognitive inflexibility and
9) avoidance of experience and emotions [29,131,132];
10) care givers’ expressed emotion [14,62,71,75];
11) poor problem solving abilities [69];12) scarce social
support [64,74]; and 13) reduced relational abilities
[39,69,133] (for a review on widely used treatment
models see: Hay and colleagues [134]). Evidence on a re-
lationship between dropout, treatment response and
both character and temperament [14,67,135] encourages
to focus on considering in detail patients’ personality.
The extension of research to areas including not only eat-
ing symptomatology seems timely and promising: clinicians
will probably obtain more instruments to understand their
patients, individualize treatments, and handle resistance.
However, to date there are no findings supporting such a
more articulate approach to AN as regards treatment re-
sponse. This model can be indeed too detailed for those pa-
tients with a less severe psychopathology [136] and RCT
are not currently available [109]. Rather- although further
studies are needed - an RCT [137] did not show any signifi-
cant effect in increasing treatment response.
For those patients with an enduring AN and consoli-
dated maintaining factors, supportive or rehabilitative
therapies have been suggested [58,87,138,139] since it is
unlikely that certain severe patients will respond to
treatments being aware of their resistance. Although
these approaches are interesting and potentially useful,
to the best of our knowledge there is still no clear con-
sensus in literature on the criteria used to define the
chronic course in the ED field [87], making even more
problematic to group those patients who would benefit
from such supportive treatments.
Therapeutic relationship, countertransference, and
management of treatment resistance
Although further research is needed, the aforementioned
studies allowed a better understanding of the AN patho-
genesis although they were not effective enough in im-
proving prognosis. Sometimes we cannot see woods for
trees and - focusing too much on specific aspects - we
could miss the overall emotive exchanges constituting
the therapeutic relationship [24,97] and its complex pat-
terns of interaction [53].
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therapeutic relationship on resistance to treatments in
AN. It is of interest that these works on one hand refer
to decades ago [89], whilst on the other have been only
recently conducted [47]. These elements show well the
gap in literature that now some authors are trying to fill
although both Bruch [97] and Garner [140] underscored
the issue of the iatrogenic effect of those therapists who
are not able to manage their own emotions. All these pa-
pers agree on the importance of emotive aspects within
the therapeutic relationship, in treating treatment-
resistant AN people. Patients themselves – when describing
their recovery process – individuate psychotherapy and re-
lationships as fundamental tools to overcome resistance
[88]. In particular, psychotherapy has been described as a
continuous and significant experience to achieve self-
validation [69]. Such opinions match some authors’ sugges-
tions highlighting the relevance of sharing treatment plans
with patients [41].
In this regard, resistance to treatments should be consid-
ered within the therapist-patient interaction [84] involving
on one hand patients’ and illness features [116] and on the
other therapist-related factors [98] and their interaction
[90]. In particular, the avoidant [66-68,79,141] and narcis-
sistic [76] personality traits of AN patients, in addition to
their disadaptive management of anger [142,143], make the
therapeutic alliance difficult, sometimes enhancing the ill-
ness and patient’s relational isolation.
In fact, EDs – assuming an overarching psychodynamic
perspective – are essentially disorders of the development
of the self and personality, as Bruch [97] originally con-
ceived and as Skårderud [24] and Stanghellini and
Coworkers [125] have recently suggested, placing emphasis
also on insecure attachment [108,144] and mentalization
impairments [120,145].
In particular, AN patients’ deep emotions are character-
ized by fear, emptiness, anger, and profound demoralization
[116,142,143,146]. The illness is a desperate and self-
harming attempt to control distress, on one hand avoiding
emotions and on the other hand expressing them in an ex-
aggerated way or developing an exasperated perfectionism
[95,147]. In general, emotion avoidance and dysregulation
are mostly related to treatment-resistance [95].
Such emotions reverberate in line with therapists’ ones,
mainly if they are young [98] or lacking supervision [81].
Particularly frustration and anger, but also despair, exces-
sive worry, boredom, and feeling of being manipulated
[81,85,98] are common when investigating therapists’
countertransference features. Resistance to treatments
itself is thought to be the most challenging aspect of the
AN treatment, according to studies conducted on clini-
cians’ perspectives [98]. In this regard, treatment-
resistance could be linked to a contagious fear of aggres-
siveness and despair that could involve the therapist too.Treatments could be influenced by an overemphasis
on cognitive [24] or explicit communication factors,
whilst the issue could be related to the avoidance of an
emotive confrontation on symptomatology and real-life
experiences or, more simply, to the lack of an authentic
relationship between patient and therapist [16]. An ef-
fective therapy to overcome resistance to treatments
could be indeed a cognitive-analytic therapy as Dare and
Coworkers [148] suggested and tested with RCT.
Psychotherapy – as well as those therapies focused on
AN symptomatology – should then help patients to
achieve a multi-dimensional understanding of them-
selves and to manage their feelings and relationships,
gradually reshaping the adaptive function of the illness.
This psychotherapeutic model was only sporadically
tested in literature [68,135] and - although it may look
outdated - it could be proposed again in the light of the
studies on psychotherapy currently available.
In fact, psychodynamic psychotherapy is currently
regaining its role in psychiatry [149], mostly as integra-
tive discipline and science of intimacy useful to achieve
a developmental psychopathology and overcoming its
traditional concept of science of interpretation [128].
Neurosciences significantly highlighted how relational
our mind is [150] and that human beings are wired to
be social [151]. Initial findings showed that shared emo-
tions can synchronize brain activity [152]: from a meta-
analytic studies of dynamic psychotherapies we now
know that they are effective in several mental disorders
[153] and that the more they consider affective and emo-
tional aspects the more effective they are [154].
In psychodynamic psychotherapies, two aspects have
been considered as key-elements: a) a secure, sensitive, and
interactive therapeutic alliance; and b) encouraging patients
to experience the previously avoided threatening feelings
[155]. It is the time to (re)introduce these therapeutic pro-
cesses in the study of AN treatments. Moreover, the con-
cept of resistance to treatments arose from psychoanalysis,
as recently remarked [156], on the basis of Freud’s state-
ments [157] clarifying that resistance is intertwined with
treatment and that it represents a compromise between the
strengths related to recovery and those opposing to it.
AN patients ask their clinicians acceptance, intensity,
challenge and mostly competence [53], confronting their
knowledge, but even more their relational skills. Being able
to provide an empathic understanding is fundamental to
train the patients to recognize themselves, and restrain
their distress with a good balance of implicit and explicit
messages in the here and now of the therapeutic relation-
ship through transference and countertransference [158].
Psychotherapy cannot be manualized enough to avoid
the unpredictability of the relationship [128]. To improve
the quality of the therapeutic relationship the therapist
needs to be authentic, implicit and empathic [128,159]. If
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profound and intense to become embodied simulation
[160], also through mirror neurons [161], therapist and
patient can start to share not only the distress but also the
ability to limit it. Studies on personality and EDs confirm
how often emotional coping can be impaired [162]. Ther-
apist’s coping skills can be a useful model to enhance the
development of patient’s coping. In fact, affected individ-
uals can implicitly feel and consider the change, starting
to overcome their resistance and fear, as like as therapists
handle their fears of being too frustrating or too sympa-
thetic with their patients [11].
In the therapeutic relationship, AN patients can ex-
perience new theories of others’ mind [163] and more
adaptive forms of reflective self-functioning [164] and
through this integration of psychic realities they will be
again more aware of their own body [24].
Unfortunately, to date there is still little in the way of
addressing the treatment-resistance issue in AN. The
studies on the importance of therapeutic relationship in
facilitating emotive experiences are still sparse or pro-
vide only pilot data [143,165]. Although an RCT has
been designed in this regard [166], further studies are
still warranted to bridge this gap.
Conclusions
Resistance to treatment and reluctance to recovery repre-
sent key-problems in the treatment of individuals affected
by AN [13,17]. In fact, affected patients often show poor
motivation to treatment entailing high levels of dropout
[14,100] and negative outcomes with the illness becoming
often chronic and eventually mortal [167].
The present work individuated 71 studies that specific-
ally addressed treatment-resistance but - although many
factors are possibly involved – a dearth of evidence-
based findings in this area emerged.
To date are available more theoretical models rather
than evidence-based studies on the most effective way to
manage treatment resistance. Future research is war-
ranted to fill these gaps and to pave the way for a better
understanding of EDs and their treatments, although a
more clear description of resistant patients emerged
from the available findings.
As Strober wrote [139], EDs do not randomly affect in-
dividuals, but a certain temperament coupled with imma-
ture, avoidant and perfectionistic personality traits make
people more vulnerable and prone to the ED onset
[162,168]. Therefore, to earn a resistant patient’s trust it is
first necessary to recognize the defensive nature of the ED
symptoms being also aware of their adaptive function to
achieve the mitigation of a profound distress [24]. Hidden
by the hyper control of body and food, the main elements
are demoralization [141], anger [142,169], low self-esteem,
and a great “hunger” of approval and reassurance. ANpatients are highly ambivalent about relationships; a disa-
daptive style of attachment poses the bases for the devel-
opment of relationships characterized by dependence and
fear of others’ opinions. Coping abilities are impaired:
emotions are ignored and avoided through alexithymia, or
are uncontrollable and destructive generating acting-out.
In a specular way, the therapist incurs the risk of becom-
ing alexithymic [170], or angry and frustrated [98].
Several aspects need to be considered to avoid these
mechanisms: expertize, firmness, awareness of maintain-
ing factors, and mostly a “relational knowledge”; accord-
ing to Roland Barthes: “no power, a little knowledge, a
little wisdom and as much flavor as possible” [171].
There is no possible treatment of symptoms and cogni-
tive distortions without attunement [128,160]. Who can
motivate the treatment-resistant patient to activate a
“voluntary suspension of distrust” [172] to overcome
such highly valuable symptoms? Only those therapists
who can empathically understand those feeling of use-
lessness, loneliness, and death that patients often experi-
ence and highly value.
Treating resistant patients is a long and winding road
entailing inevitable multiple problems in the therapeutic
alliance. A secure and firm relationship and the avoidance
of premature interpretations and arrogant approaches are
both effective elements in fostering a positive therapeutic
relationship; it is also fundamental indeed to accept and
respect patients’ thoughts and wishes [97].
Patients should be provided with a chance to express
themselves – even with difficulty – since their most au-
thentic parts are likely to reemerge from the eating obses-
sions and regain meaning. Only then the psychotherapeutic
interventions will not be a priori refused but implemented
and sustained by the patients who will be free to regain
confidence with their own personality and experiences,
also related to food and body. Patients’ profound de-
moralization [107] will be then mitigated with an en-
couraging relational strategy [173-175] aimed at the
development of the self [97].
Is this approach possible in this economic climate and
with the current strong need for cost-effective interven-
tions? It could be feasible whether public health policies
will be able to consider wider investments also because
AN-related costs are considerable and –according to the
available data - may be even underestimated [176]. It is
well-known that an incorrect treatment of these disor-
ders could entail patients’ frustration and increase costs
[177]. Other severe and resistant psychiatric disorders
could benefit from intensive interventions with eco-
nomic advantages over the medium-term [178,179]; in
fact, costs tend to be higher if a correct psychothera-
peutic approach is not provided [180].
The dearth of ED programs may be due to the lack of
proper knowledge with sometimes clinicians’ attitudes
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services [98].
In the future it will be indeed necessary a strong effort
as regards both public health decisions and clinical
training to finally improve ED treatments and prognosis
[167], mostly because these disorders affect young indi-
viduals and are still largely unclear.
This overview shows some limitations. First, the pos-
sible biological factors related to resistance have not
been considered. Second, resistance could be addressed
also by other articles that are not specifically dedicated
to this issue and so we could have omitted some papers.
Third, this wide heterogeneity made it particularly chal-
lenging to systematically and critically review the papers
included in the present work. Therefore, they have been
clinically and theoretically discussed. Finally, the need to
synthesize such complex and wide topics may have left
some aspects not fully covered.
Further studies will have to validate the need for per-
sonalized treatments – mostly psychotherapies - [16,181]
and for interventions tailored to personality dimensions
to attenuate resistance and prevent dropouts. This state-
ment is not in line with some studies [182,183] highlight-
ing that ED treatments – including the specialist
supportive clinical management - are all equally effective.
But these studies show a relevant selection [184] and
randomization bias: patients did not receive a tailored
treatment but a default intervention that did not con-
sider patients’ peculiar meaning of the disorder. Such re-
search methods can indeed uniform results and
potentialities of treatments. The negative emotions that
underpin the eating symptomatology [147] should be
properly addressed with individualized interventions
[148]. A recent RCT [185] demonstrated that focal psy-
chodynamic therapy is an effective treatment for AN. It
could represent a promising therapeutic opportunity
mostly for those patients who are resistant to treatment
since psychodynamic psychotherapy can be highly indi-
vidualized. Further studies testing the application of this
intervention also on resistant patients are needed.
In psychiatry, the therapeutic relationship - crucial also
during medication prescription [186] - shows even more
importance in psychotherapy [187]: the overcoming of re-
sistance to treatment in AN cannot be possible without a
deep patients’ understanding, mostly regarding their pro-
found and unique despair, and without sharing with them a
long and difficult therapeutic journey [124]. Patients can fi-
nally achieve a more mature personality balancing their def-
icits of the self with strategies to regain confidence in their
body and to favorably give up the eating symptomatology.
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